Efficacy of neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer (the NHIPEC trial): study protocol for a randomised controlled trial

Efficacy of neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer (the NHIPEC trial): study protocol for a randomised controlled trial

Background Neoadjuvant chemotherapy (NACT) is an important treatment option for patients with ovarian cancer. Although intravenous NACT can improve optimal resection rates and decrease surgical morbidity and mortality, these advantages do not translate into a survival benefit. Ovarian carcinoma is m...

Full description

Saved in:
Bibliographic Details
Main Authors: Hui Zhou, Jing Li, Qing Chen, Ji-Bin Li, Li-juan Wang, Yan-Fang Ye, Miao-Fang Wu, Chang-Hao Liu, Huai-Wu Lu, Ting-Ting Yao, Bing-Zhong Zhang, Yong-Pai Peng, Zhong-Qiu Lin
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/12/e046415.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/11/12/e046415.full

Similar Items